George Cassels-Smith, c.e.o of Tobacco Technologies (TTI) and director of Zanoprima Lifesciences
Synthetic nicotine, used in new generation products, comes from the lab and not from the tobacco plant itself, which - until now - provided a regulatory escape route for some products manufacturers. Now, FDA regulate e-cigarettes and similar products using synthetic nicotine the same as those using plant-derived nicotine. Clarifying what the situation is today is Tobacco Asia's podcast guest George Cassels-Smith, well known c.e.o of Tobacco Technologies (TTI) and also director of Zanoprima Lifesciences, a supplier of SynNic synthetic nicotine. He discusses the regulations, uses, and the future of synthetic nicotine.
The Tobacco Asia podcast is brought to you in conjunction with Business Insights, the new digital platform of Messe Dortmund and their InterTabac/InterSupply events, the world’s leading and largest tobacco exhibitions, and hosted by Thomas Schmid, contributing editor at Tobacco Asia.